XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings per Share Data
6 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Earnings per Share Data

Note 5 — Earnings per Share Data

The Condensed Consolidated Financial Statements include basic and diluted earnings per share information. The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended March 31, 2019 and 2018:

 

     Quarter Ended March 31,      Six Months Ended March 31,  
     2019      2018      2019      2018  

Net Income

   $ 7,460,000      $ 3,764,000      $ 7,773,000      $ 6,110,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Common Shares:

           

Weighted average common shares outstanding

     14,541,000        14,482,000        14,541,000        14,470,000  

Effect of dilutive stock options

     167,000        246,000        164,000        255,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted shares outstanding

     14,708,000        14,728,000        14,705,000        14,725,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic:

           

Net earnings per share

   $ 0.51      $ 0.26      $ 0.53      $ 0.42  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted:

           

Net earnings per share

   $ 0.51      $ 0.26      $ 0.53      $ 0.41  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic earnings per share is based on the weighted-average number of shares outstanding. Diluted earnings per share is based on the sum of the weighted-average number of shares outstanding plus common stock equivalents.

The weighted-average shares issuable upon the exercise of stock options included in the diluted earnings per share calculation for the quarter and six months ended March 31, 2019 were 317,000 and 317,000, respectively, which equates to 167,000 and 164,000 dilutive common stock equivalents, respectively. The weighted-average shares issuable upon the exercise of stock options included in the diluted earnings per share calculation for the quarter and six months ended March 31, 2018 were 377,000 and 389,000, respectively, which equates to 246,000 and 255,000 dilutive common stock equivalents, respectively. There were no anti-dilutive shares for the quarters and six month periods ended March 31, 2019 and 2018.